Braveheart Investment Group PLC (LON:BRH) has said the clinical sample pipeline for the COVID-19 test developed by its investee Paraytec is now fully operational.
Joining Proactive London to explain the science is Professor of Cell Biology at University of Sheffield, and academic lead for the Covid-19 project in collaboration with Paraytec Ltd, Carl Smythe.
Paraytec is collaborating with the University of Sheffield, with both focusing on the first 500 samples received from Sheffield Hospitals Trust over the last month.